Spanish Neurology Biotech Launches with €7.6M Series A
Accure Therapeutics, a neurology biotech targeting central nervous system (CNS) conditions such as multiple sclerosis…
May 29, 2020 - 3 minutes
Neurological disorders
Phase III Failure Sinks Drug for Rare Neurological Disorder
The Italian biotech Newron is halting the development of the experimental drug sarizotan after it…
May 8, 2020 - 4 minutes
AskBio Takes Over French Gene Therapy Company to Treat Alzheimer’s and Huntington’s
The Paris-based BrainVectis, a biotech developing gene therapies for Huntington’s disease and Alzheimer’s disease, has…
April 28, 2020 - 3 minutes
Idorsia’s Drug Improves Sleep in First Phase III Trial for Insomnia
The Swiss pharmaceutical company Idorsia has announced that its drug candidate daridorexant significantly improved sleep…
April 21, 2020 - 3 minutes
Two European Alzheimer’s Disease Treatments Show Promise in Phase II
An epigenetics drug developed by the Spanish biopharmaceutical company Oryzon has reduced aggressive behavior in…
April 9, 2020 - 4 minutes
Eli Lilly Sweetens AC Immune Alzheimer’s Treatment Deal by €38M
A deal between Swiss biotech AC Immune and Eli Lilly to develop an oral Alzheimer’s…
March 24, 2020 - 3 minutes
Phase III Fail for MedDay’s Multiple Sclerosis Treatment
A drug developed by the French company MedDay Pharmaceuticals has failed to treat progressive forms…
March 11, 2020 - 2 minutes
Scientists Connect Brain Cells to Machines Over the Internet
An international group of researchers has set up a brain-machine interface between cultured nerve cells…
February 27, 2020 - 3 minutes
EU Project Set up to Fight Alzheimer’s Disease with Lasers
A project has launched with a €3.6M grant to treat neurological conditions such as Alzheimer’s…
February 7, 2020 - 3 minutes
Swiss Biotech Raises €16M to Treat Autism Spectrum Disorder
Stalicla has bagged €16.3M in a Series A round to test drugs repurposed using AI…
February 4, 2020 - 2 minutes
As Big Pharma Abandons Neuroscience, Can Biotech Provide Answers?
With big pharma exiting the neurology space in droves, biotech innovation might be the key…
December 9, 2019 - 9 minutes
Orchard’s Gene Therapy Improves Children’s Motor Ability
Orchard Therapeutics' gene therapy for metachromatic leukodystrophy (MLD) resulted in motor ability improvements more than…
September 5, 2019 - 3 minutes
